Security record · archived quarter
VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
7Tracked holders
0Δ holders
1.73MShares held
$1.92MReported value
+0New positions
−0Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -6.6% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | — | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | — | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | — | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | — | — |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | — | 1.49M | $1.49M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 529.50K | -30.0% | $587,745 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 422.14K | 0.0% | $468,712 | 0.0% | Held | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 422.14K | 0.0% | $468,712 | 0.0% | Held | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 261.84K | -13.8% | $290,639 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 200.41K | +28007.3% | $222,450 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 163.06K | +18.9% | $181,001 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (passive) | 115.93K | — | $128,687 | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 37.19K | -68.1% | $41,281 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 37.19K | -68.1% | $41,281 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 79 holders, 40.44M shares, $716.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API